48.4% of participants reported tumor regression or no evidence of diseas
36.1% reported stable disease and
15.6% reported progression
pdf attached
48.4% of participants reported tumor regression or no evidence of diseas
36.1% reported stable disease and
15.6% reported progression
pdf attached
2nd'd